Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 546.23 billion as of October 10, 2025. Its market cap has increased by 18.26% in one year.

Market Cap

546.23B

Enterprise Value

553.90B

Revenue

134.56B

Ranking

n/a

PE Ratio

72.47

Stock Price

1,935.70

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 546.23B, an increase of 47,426.87%. That is a compound annual growth rate of 28.80%.

Market Cap History

Date	Market Cap	% Change
Oct 9, 2025	546.23B	20.30%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	18.50T
HDFC Bank	15.03T
Bharti Airtel	11.65T
Tata Consultancy Services	10.95T
ICICI Bank	9,789.73B
State Bank of India	7,922.18B
Bajaj Finance	6,351.84B
Infosys	6,197.23B

Market Cap Rankings